Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
11/12Earnings Release
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 21,39
PER 2012
Capi. / Sales 2011 4,50x
Capi. / Sales 2012 27,9x
Capitalization 27,0 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
10/02 INTELGENX TECHNOLOGIES : 2014-10-02 IntelGenx Founder Returns as President and C..
10/02 IntelGenx Founder Returns as President and CEO
10/01 IntelGenx and RedHill Biopharma Submit European Marketing Authorization Appli..
09/17 INTELGENX TECHNOLOGIES : 2014-09-17 IntelGenx to Present at Singular Research 9t..
09/17 IntelGenx to Present at Singular Research 9th Annual Best of the Uncovereds C..
08/21 INTELGENX TECHNOLOGIES : 2014-08-21 IntelGenx to Present at the Rodman & Renshaw..
08/21 IntelGenx to Present at the Rodman & Renshaw Global Investment Conference
08/07 IntelGenx Reports Q2, 2014 Results and Provides Corporate Development Update
08/07 INTELGENX TECHNOLOGIES : 2014-08-07 IntelGenx Reports Q2, 2014 Results and Provi..
07/22 INTELGENX TECHNOLOGIES : 2014-07-18 IntelGenx to Host Management Call
07/18 INTELGENX TECHNOLOGIES : 2014-07-15 IntelGenx to Host Management Call
07/18 IntelGenx to Host Management Call
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF